Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 20 · below the Ichimoku cloud · RSI 41 · MACD below its signal · 5% above its 52-week low
None of the 29 investors followed here reported a position in CPHN.SW in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CPHN.SW trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for CPHN.SW.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.6 | -2.4 | -11.6 | -1.0 | 0.7 | -4.8 | 5.1 | 1.7 | 1.4 | -5.7 | −18.5% | ||
| 2025 | 8.7 | -11.5 | -4.2 | -2.1 | 4.5 | 6.9 | 2.2 | -9.3 | 5.0 | -2.8 | -1.1 | 0.0 | −5.7% |
| 2024 | 5.4 | -5.1 | 3.3 | -2.1 | 4.9 | -23.9 | -1.7 | -2.1 | 2.1 | 3.3 | -2.0 | 7.6 | −13.6% |
| 2023 | 10.8 | 5.8 | -2.6 | 0.2 | 2.0 | -7.0 | 2.8 | 0.0 | -2.3 | -4.9 | -1.2 | 6.5 | +9.0% |
| 2022 | -3.3 | 9.8 | 0.3 | 0.9 | 0.3 | 10.9 | 0.3 | 1.4 | -5.1 | 0.6 | 9.3 | 0.8 | +27.9% |
| 2021 | -0.3 | -7.5 | -6.6 | 1.0 | -3.8 | 14.5 | -3.7 | -0.9 | 7.8 | -1.4 | -9.6 | -4.4 | −16.0% |
| 2020 | 0.0 | -2.8 | -13.8 | 0.6 | 12.3 | -9.3 | 1.5 | -3.2 | 0.3 | -6.0 | 2.2 | 12.7 | −8.3% |
| 2019 | -0.6 | 7.3 | -3.4 | -0.5 | -0.9 | -0.5 | -1.0 | -1.9 | -0.7 | -0.5 | -1.5 | 0.5 | −4.0% |
| 2018 | 23.2 | 4.5 | 1.4 | 12.9 | 3.8 | 3.7 | 3.5 | -2.3 | 2.9 | -2.3 | -2.9 | -1.8 | +54.1% |
| 2017 | 0.0 | 13.8 | 4.4 | 3.1 | 0.1 | -1.2 | 11.6 | 2.1 | 1.7 | 0.9 | -3.4 | -2.1 | +33.9% |
| 2016 | -2.5 | 2.9 | 19.4 | -14.9 | -3.1 | 0.6 | 29.3 | -2.1 | 0.3 | 0.0 | -3.0 | 4.2 | +27.4% |
| 2015 | -15.4 | 4.3 | -3.3 | -1.0 | -2.5 | -9.1 | -7.7 | 2.6 | -19.3 | 4.6 | -3.8 | -3.4 | −44.4% |
| 2014 | -1.6 | 2.8 | -0.7 | -0.8 | -0.2 | 2.0 | -0.5 | -2.1 | -0.3 | -2.5 | 1.7 | -5.9 | −8.2% |
| 2013 | -3.1 | -0.9 | -0.8 | 3.2 | -2.3 | -0.4 | -0.2 | -0.4 | 2.2 | -1.3 | -2.2 | 0.8 | −5.4% |
| 2012 | 22.1 | 13.5 | -0.1 | 0.7 | -9.3 | 1.7 | -2.3 | -3.1 | 5.6 | -0.6 | 0.4 | 0.2 | +28.7% |
| 2011 | -2.4 | -1.7 | -1.8 | -0.6 | -2.7 | -15.7 | -2.2 | -8.2 | -1.7 | -1.7 | -7.1 | -3.8 | −40.6% |
| 2010 | 2.3 | -11.2 | 2.8 | -2.1 | -7.5 | -6.8 | -1.1 | 1.8 | 1.4 | -2.0 | 8.0 | 14.1 | −2.9% |
| 2009 | -7.0 | -7.3 | -8.7 | 27.2 | -3.9 | 1.3 | 2.6 | 25.2 | -2.1 | 0.5 | -4.5 | -4.1 | +13.0% |
| 2008 | -15.5 | -7.6 | -12.3 | 12.3 | 0.9 | -2.4 | -6.5 | 3.8 | -13.4 | -15.2 | -7.4 | -6.1 | −53.1% |
| 2007 | 2.0 | 0.3 | -1.7 | 12.8 | 23.3 | -1.9 | 1.1 | -3.6 | -4.5 | 2.0 | -12.9 | 8.2 | +22.9% |
Buy / hold / sell counts
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.
No recent headlines.